Vijaypd Ceutical Ltd
VIJAYPD NSE
Vijaypd Ceutical Ltd
RetailNSE: VIJAYPD Pharmacy Retail
Key Fundamentals
SMEPharmacy RetailRetailMarket Cap
₹121 Cr
Volatility
Moderate
P/E Ratio
23.5
EBITDA
₹4.71 Cr
Return on Equity
14.91%
Debt to Equity
0.64
Book Value
₹26.88
52W High
₹114.5
52W Low
₹35
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Vijaypd Ceutical Ltd insights
29 extracted metrics + investor summaries across FY23–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Weaknesses
5- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.4.02 Cr.
- Debtor days have increased from 85.8 to 115 days.
- Working capital days have increased from 21.1 days to 64.7 days
Growth Rate
Revenue Growth
-16.06% ↘
Net Income Growth
-1.46% ↘
Cash Flow Change
-
ROE
-40.46% ↘
ROCE
-55.57% ↘
EBITDA Margin (Avg.)
-42.52% ↘
Quarterly Results
| Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales | 50.32 | 49.91 | 51.33 | 47.62 |
| Expenses | 44.84 | 46.99 | 46.97 | 47.27 |
| Operating Profit | 5.48 | 2.92 | 4.36 | 0.35 |
| OPM % | 10.89% | 5.85% | 8.49% | 0.73% |
| Other Income | 0.01 | 0.75 | 0.32 | 3.7 |
| Interest | 1.17 | 0.98 | 1.06 | 0.53 |
| Depreciation | 0.3 | 0.31 | 0.28 | 0.34 |
| PBT | 4.02 | 2.38 | 3.34 | 3.18 |
| Tax % | 26.62% | 26.05% | 27.84% | 16.67% |
| Net Profit | 2.95 | 1.76 | 2.42 | 2.64 |
| EPS in Rs | 4.21 | 1.25 | 1.73 | 1.35 |
Profit & Loss
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales | 51.09 | 59.15 | 117 | 98.96 |
| Expenses | 49.77 | 54.27 | 109 | 94.25 |
| Operating Profit | 1.32 | 4.88 | 8.58 | 4.71 |
| OPM % | 2.58% | 8.25% | 7.33% | 4.76% |
| Other Income | 1.82 | 0 | 0.78 | 4.02 |
| Interest | 2.36 | 1.76 | 2.15 | 1.59 |
| Depreciation | 0.43 | 0.35 | 0.69 | 0.62 |
| PBT | 0.35 | 2.77 | 6.52 | 6.52 |
| Tax % | 48.57% | 40.43% | 26.53% | 22.39% |
| Net Profit | 0.18 | 1.65 | 4.8 | 5.06 |
| EPS in Rs | — | — | 3.42 | 2.59 |
| Div. Payout % | 0% | 0% | 0% | 0% |
Balance Sheet
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 0 | 1 | 14.03 | 19.53 |
| Reserves | 4.93 | 5.59 | 18.14 | 33.01 |
| Borrowings | 25.57 | 24.45 | 21.77 | 33.67 |
| Other Liabilities | 2.37 | 2.23 | 3.21 | 11.15 |
| Total Liabilities | 32.87 | 33.27 | 57.15 | 97.36 |
| Fixed Assets | 2.73 | 2.43 | 8.44 | 8.72 |
| CWIP | 0 | 0 | 0.11 | 1.66 |
| Investments | 0.16 | 0.15 | 0.25 | 2.09 |
| Other Assets | 29.98 | 30.69 | 48.35 | 84.89 |
| Total Assets | 32.87 | 33.27 | 57.15 | 97.36 |
Cash Flow
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Operating | 0.3 | 2.93 | -7.89 | -7.32 |
| Investing | -0.09 | 12.78 | -0.55 | -12.17 |
| Financing | -0.18 | -1.86 | -2.38 | 25.37 |
| Net Cash Flow | 0.03 | 13.84 | -10.82 | 5.88 |
| Free Cash Flow | 0.28 | 2.87 | -8.64 | -9.46 |
| CFO/OP | 38 | 60 | -80 | -128 |
Ratios
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor Days | 62.44 | 68.56 | 74.19 | 115 |
| Inventory Days | 30.97 | 28.85 | 42.6 | 46.48 |
| Days Payable | 15.44 | 5.13 | 7.71 | 31.77 |
| Cash Conversion Cycle | 77.96 | 92.29 | 109 | 129 |
| Working Capital Days | -83.94 | -60.1 | 58.73 | 64.69 |
| ROCE % | — | 14.75% | 20.4% | 11.59% |
Documents
1
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
3 Jul - Vijaypd Ceutical says corporate governance report not required for quarter ended 30 June 2026 under NSE EMERGE exemption. 3 Jul - Vijaypd Ceutical says corporate governance report not required for quarter ended 30 June 2026 under NSE EMERGE exemption.
2
Certificate under SEBI (Depositories and Participants) Regulations, 2018
3 Jul - Regulation 74(5) certificate for quarter ended 30 June 2026 filed. 3 Jul - Regulation 74(5) certificate for quarter ended 30 June 2026 filed.
3
Reply to Clarification- Financial results
1 Jul - NSE query clarified; revised consolidated half-yearly financial figures submitted for March 2026. 1 Jul - NSE query clarified; revised consolidated half-yearly financial figures submitted for March 2026.
4
Disclosure under SEBI Takeover Regulations
16 Jun - Promoter group disclosed no encumbrance on Vijaypd Ceutical shares during FY2025-26. 16 Jun - Promoter group disclosed no encumbrance on Vijaypd Ceutical shares during FY2025-26.
5
Disclosure under SEBI Takeover Regulations
16 Jun - Promoter disclosed no encumbrance on company shares for FY ended 31 March 2026. 16 Jun - Promoter disclosed no encumbrance on company shares for FY ended 31 March 2026.
Frequently Asked Questions about Vijaypd Ceutical Ltd
What does Vijaypd Ceutical Ltd do?
Incorporated in October 1971, Vijaypd Ceutical Limited distributes pharmaceutical products and consumer goods, offering a comprehensive range of services.[1]
Where is Vijaypd Ceutical Ltd (VIJAYPD) listed?
Vijaypd Ceutical Ltd is listed on the Indian stock exchanges. It is listed on NSE: VIJAYPD. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Vijaypd Ceutical Ltd belong to?
Vijaypd Ceutical Ltd operates in the Retail sector within the Pharmacy Retail industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Vijaypd Ceutical Ltd?
Vijaypd Ceutical Ltd has a market capitalisation of approximately ₹121.08 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Vijaypd Ceutical Ltd?
The Price-to-Earnings (PE) ratio of Vijaypd Ceutical Ltd is 23.50. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Vijaypd Ceutical Ltd?
Over the past 52 weeks, Vijaypd Ceutical Ltd has traded between a low of ₹35 and a high of ₹114.5. This range helps investors understand the stock's price volatility and recent trading levels.
What is the Return on Equity (ROE) of Vijaypd Ceutical Ltd?
Vijaypd Ceutical Ltd has a Return on Equity (ROE) of 14.91%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Vijaypd Ceutical Ltd on Tapetide?
On Tapetide, you can view Vijaypd Ceutical Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Incorporated in October 1971, Vijaypd Ceutical Limited distributes pharmaceutical products and consumer goods, offering a comprehensive range of services.[1]